Nareg Sagherian joins FTI as managing director in strategic communications segment

FTI Consulting, Inc. announces the appointment of Nareg Sagherian as a managing director within the Strategic Communications segment. Based in Washington, D.C., Mr. Sagherian will report to Charlene MacDonald, a managing director in the Company’s Healthcare & Life Sciences sector for Strategic Communications.

Mr. Sagherian will help healthcare and life sciences clients develop and execute communication programs related to mergers and acquisitions, IPOs, shareholder activism, and a range of capital market events and financial transactions. His expertise spans investor relations, capital raising communications, valuation analysis, reputation management, stakeholder engagement, crisis communications and coalition building.

“Nareg’s appointment emphasizes our commitment to helping healthcare and life science clients navigate their most pressing challenges and areas of opportunity,” said Brian Kennedy, Head of the Americas for FTI Consulting’s Strategic Communications segment. “His broad financial expertise will benefit clients as they look to protect and enhance business value in today’s dynamic and complex market environment.”

Mr. Sagherian joins FTI Consulting following his position as Managing Director of Investor Relations and Programming at the Biotechnology Innovation Organization (“BIO”), a global trade association representing the biotechnology and pharmaceutical industries. Before BIO, Mr. Sagherian spent three years at the U.S. Small Business Administration, most recently serving as Chief Commercialization Strategist, playing an instrumental role in developing several key programs. He also served as an International Economist within the Office of International Affairs at the U.S. Department of the Treasury, analyzing Eurasian economic, development, financial, trade, investment, and energy and environment issues.

Commenting on his appointment, Mr. Sagherian said, “I am excited to join FTI Consulting at this critical point for the healthcare and life sciences sector. I look forward to working with this market-leading team of experts to help clients manage financial issues throughout the corporate lifecycle.”

Mr. Sagherian is an MBA candidate at the University of Virginia Darden School of Business. He has a Graduate Diploma in Legislative Studies from the Government Affairs Institute at Georgetown University, a Master of Science in Medical Sciences from the Wayne State University School of Medicine, and a Master of Science in Corporate Finance and a Graduate Diploma in Investments from the Johns Hopkins University Carey Business School.